ZA200900992B - 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors - Google Patents
2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsInfo
- Publication number
- ZA200900992B ZA200900992B ZA200900992A ZA200900992A ZA200900992B ZA 200900992 B ZA200900992 B ZA 200900992B ZA 200900992 A ZA200900992 A ZA 200900992A ZA 200900992 A ZA200900992 A ZA 200900992A ZA 200900992 B ZA200900992 B ZA 200900992B
- Authority
- ZA
- South Africa
- Prior art keywords
- pyrazo
- pyrimido
- pyrido
- methylmorpholine
- pyrimidine derivatives
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82331106P | 2006-08-23 | 2006-08-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200900992B true ZA200900992B (en) | 2010-07-28 |
Family
ID=41175600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200900992A ZA200900992B (en) | 2006-08-23 | 2009-02-11 | 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101558067B (en) |
UA (1) | UA96304C2 (en) |
ZA (1) | ZA200900992B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102887895B (en) * | 2011-07-22 | 2016-08-24 | 山东轩竹医药科技有限公司 | Pyridopyrimidine class mTOR inhibitors |
CN103588792B (en) * | 2013-03-04 | 2016-03-23 | 中国科学院上海药物研究所 | Pyridopyrimidine or pyrimido-pyrimidine compounds, its preparation method, medical composition and its use |
CN104557913B (en) * | 2013-10-28 | 2017-02-08 | 上海汇伦生命科技有限公司 | Pyridopyrimidine compounds as well as preparation method and application thereof |
CN103908452A (en) * | 2014-02-18 | 2014-07-09 | 广州金域医学检验中心有限公司 | Composite drug and medicinal preparation for inhibiting lung cancer cell metastasis and detection method for lung cancer cell metastasis |
CN106008559B (en) * | 2015-03-25 | 2020-10-16 | 中国科学院上海药物研究所 | Synthesis process of substituted pyridopyrimidine compounds |
JP7340519B2 (en) * | 2017-11-06 | 2023-09-07 | メッドシャイン ディスカバリー インコーポレイテッド | Pyridopyrimidine compounds as mTORC1/2 dual inhibitors |
CN110407833B (en) * | 2018-04-28 | 2021-03-09 | 海创药业股份有限公司 | Deuterated Vissturtib compound and application thereof |
WO2020147842A1 (en) * | 2019-01-18 | 2020-07-23 | 南京明德新药研发有限公司 | Use of pyridopyrimidine compounds in preparation of drug for treating nasopharyngeal carcinoma |
WO2020224585A1 (en) * | 2019-05-06 | 2020-11-12 | 南京明德新药研发有限公司 | Salt and crystal form of mtorc1/2 dual kinase activity inhibitor and preparation method therefor |
CN111892529A (en) * | 2020-08-19 | 2020-11-06 | 南通大学 | 6-chloro-5-hydroxyisoindole-1-one and synthesis method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5990117A (en) * | 1998-04-15 | 1999-11-23 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivatives |
WO2001083456A1 (en) * | 2000-04-27 | 2001-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | Condensed heteroaryl derivatives |
JP5161102B2 (en) * | 2005-11-22 | 2013-03-13 | クドス ファーマシューティカルズ リミテッド | Pyridopyrimidine, pyrazopyrimidine and pyrimidopyrimidine derivatives as mTOR inhibitors |
-
2007
- 2007-08-21 UA UAA200902219A patent/UA96304C2/en unknown
- 2007-08-21 CN CN200780038974.7A patent/CN101558067B/en active Active
-
2009
- 2009-02-11 ZA ZA200900992A patent/ZA200900992B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101558067B (en) | 2014-05-28 |
CN101558067A (en) | 2009-10-14 |
UA96304C2 (en) | 2011-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT2057156T (en) | 2-methylmorpholine pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors | |
HK1124039A1 (en) | PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS | |
ZA200900992B (en) | 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors | |
HK1117159A1 (en) | Pyrrolidine derivatives as erk inhibitors | |
EP2078001B8 (en) | Diazepane-acetamide derivatives as selective 11 -hsd1 inhibitors | |
ZA200807447B (en) | Thieno-Pyridine derivatives as MEK inhibitors | |
PL2094263T3 (en) | 2-adamantyl-butyramide derivatives as selective 11 beta-hsd1 inhibitors | |
IL194755A0 (en) | Pyrimidine derivatives as pi3k inhibitors | |
IL198247A0 (en) | Indazole derivatives useful as l-cpt1 inhibitors | |
ZA200700181B (en) | Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors | |
HK1107348A1 (en) | Indozolone derivatives as 11b-hsd1 inhibitors | |
HK1139137A1 (en) | Acylaminopyrazoles as fgfr inhibitors | |
ZA200808966B (en) | Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors | |
EP2015745A4 (en) | Macrocyclic kinase inhibitors | |
HK1134298A1 (en) | Substituted estratrien derivatives as 17beta hsd inhibitors 17hsd | |
IL196000A0 (en) | 2-arylindole derivatives as npges-i inhibitors | |
IL194491A0 (en) | Thiazolyldihydroindazole derivatives as protein kinase inhibitors | |
ZA200804104B (en) | Pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors | |
IL196807A0 (en) | Inhibitors for glyt-1 | |
ZA200809113B (en) | Pyrimidine derivatives as p13k inhibitors | |
SI1954699T1 (en) | PYRIDO-, PYRAZO- AND PYRIMIDOPYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |